ESTRO Multidisciplinary Management of Breast Cancer 2017

Take home message for Homogeneity

Dose homogeneity: solid evidence from clinical trials

Remember the distinction between

forward IMRT (use with no restriction ☺ )

inverse planned IMRT /VMAT

Role IMRT / DIBH for dose reduction to OARs (see Tuesday)

03/01/13